Ambroxol for parkinson disease

A treatment and a condition, followed through the public trial records. Not medical advice. How a status is set

Trial registered. A trial in people is registered. As of 19 Nov 2026, from 1 registered trial.

Why this status

  1. 26 Sep 2016: Trial registered, NCT02914366

The trials

How the status changed

  1. 19 Nov 2026: First set: Trial registered

About the treatment

Kind of treatment: Drug.

Also known as Tabcin.

Registries searched: ClinicalTrials.gov, through 17 Nov 2026.